ArticleFrontiers in pharmacology2024

Erratum: Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors.

Frontiers Production OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.